Sources Used in Current Review
2020 review performed by Morgan E. Pacini, MS, Technical/General Supervisor, LSA Toxicology Laboratory.
(July 3, 2019) Chan, B. Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4). Clinical Toxicology. Available online at https://www.tandfonline.com/doi/full/10.1080/15563650.2018.1546010?scroll=top&needAccess=true. Accessed on 4/12/2020.
(January 7, 2020) Thibault, N. Effect of eliglustat on the pharmacokinetics of digoxin, metoprolol, and oral contraceptives and absorption of eliglustat when coadministered with acid-reducing agents. Molecular Genetics and Metabolism. Available online at https://www.sciencedirect.com/science/article/pii/S1096719219305463. Accessed on 4/14/2020.
(May 8, 2019) Bennett, S. Use of digoxin in heart failure. Journal of Prescribing Practice. Available online at https://www.magonlinelibrary.com/doi/abs/10.12968/jprp.2019.1.5.224. Accessed on 4/11/2020.
University of Illinois-Chicago, Drug Information Group. (2018). Digoxin, Oral Tablet. Healthline. Available online at https://www.healthline.com/health/digoxin-oral-tablet. Accessed on 4/10/2020.
(March 19, 2017) AFib Patients Taking Digoxin Have Increased Risk of Death. ACC News Story. Available online at https://www.acc.org/latest-in-cardiology/articles/2017/03/13/17/58/sun-1045-am-aristotle-digoxin-and-mortality-in-afib-patients-with-and-without-hf-acc-2017. Accessed on 4/14/2020.
Sources Used in Previous Reviews
A Manual of Laboratory & Diagnostic Tests. 6th ed. Fischbach F, ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
Clinical Chemistry: Principles, Procedures, and Correlations. Bishop M, Duben-Engelkirk J, Fody E, eds. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
Sacher RA, McPherson RA, Campos J. Widmann’s Clinical Interpretation of Laboratory Tests. 11th ed. Philadelphia: F.A. Davis Company; 2000.
Goodman & Gilman’s The Pharmacological Basis Of Therapeutics. 11th Edition. Lazo J, Goodman L S, Parker K L, eds, McGraw-Hill, September 2005.
National Heart, Lung, and Blood Institute (September 2003). Heart and Vascular Diseases: Heart Failure: Summary page (On line information). Available onlin at https://www.nhlbi.nih.gov/health/dci/Diseases/Hf/HF_All.html.
Terra, S G, Washam J B, Dunham, G D, and Gattis W A, (Oct 1999). Therapeutic Range of Digoxin’s Efficacy in Heart Failure: What Is the Evidence? Pharmacotherapy, 19(10): 1123-1126, (On line journal). Available online at https://www.medscape.com/viewarticle/418044.
Gibbs C R, Davies M K Davies, Lip G Y H, (Feb 2000). Management: Digoxin and other inotropes, Beta-blockers, and antiarrhythmic and antithrombotic treatment, BMJ. 320(7233): 495-498. PDF available for download at https://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1127534.
Mihai Gheorghiade, MD; Kirkwood F. Adams, Jr, MD; Wilson S. Colucci, MD (2004). Digoxin in the Management of Cardiovascular Disorders, Circulation; 109:2959-2964 (On line journal). Available online through https://circ.ahajournals.org.
Rich, M. (2003 September). Drug Therapy of Heart Failure in the Elderly. Am J Geriatr Cardiol 12(4):235-242 (On line journal). Available online at https://www.medscape.com/viewarticle/460844.
Yusuf, S (November 1997). Digoxin in heart failure: results of the recent digoxin investigation group trial in the context of other treatments for heart failure Eur Heart J, 18: 1685-1688. PDF available for download through https://eurheartj.oxfordjournals.org.
The Digitalis Investigation Group, (February 1997). The Effect Of Digoxin on Mortality and Morbidity in Patients with Heart Failure, NEJM volume 336:525-533 (On line journal). Available online at https://content.nejm.org/cgi/content/full/336/8/525.
Catherine A. Hammett-Stabler, PhD, DABCC, FACB. Pathology and Laboratory Medicine, UNC-Chapel Hill.
Pagana, K. D. & Pagana, T. J. (© 2007). Mosby’s Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 361-364.
Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition: Saunders Elsevier, St. Louis, MO. Pp 1334-1335.
(Revised 2010 January). What is Heart Failure? National Heart Lung and Blood Institute [On-line information]. Available online at https://www.nhlbi.nih.gov/health/dci/Diseases/Hf/HF_WhatIs.html. Accessed February 2010.
A.D.A.M. Editorial Team (Updated 2009 February 3). Cardiac glycoside overdose. MedlinePlus Medical Encyclopedia [On-line information]. Available online at https://www.nlm.nih.gov/medlineplus/ency/article/002581.htm. Accessed February 2010.
Dugdale, D. (Updated 2009 January 23). Digitalis toxicity. MedlinePlus Medical Encyclopedia [On-line information]. Available online at https://www.nlm.nih.gov/medlineplus/ency/article/000165.htm. Accessed February 2010.
Ahmed, A. (2008 May 21). An Update on the Role of Digoxin in Older Adults with Chronic Heart Failure. Medscape Today from Geriatrics & Aging 2008;11(1):37-41 [On-line information]. Available online at https://www.medscape.com/viewarticle/573855. Accessed February 2010.
Patel, V. and James, P. (Updated 2010 January 6). Digitalis Toxicity. eMedicine [On-line information]. Available online at https://emedicine.medscape.com/article/154336-overview. Accessed February 2010.
Digitalis toxicity. Medline Plus Medical Encyclopedia. Available online at https://www.nlm.nih.gov/medlineplus/ency/article/000165.htm. Last updated January 13, 2013. Accessed July 26, 2013.
Digoxin Drug Level. Health Encyclopedia. University of Rochester Medical Center. Available online at https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=167&ContentID=digoxin_drug_level. Accessed July 26, 2013.
Moffett BS, Valdes SO, Kim JJ. Possible digoxin toxicity associated with concomitant ciprofloxacin therapy. Int J Clin Pharm. 2013 Abstract available online at https://www.ncbi.nlm.nih.gov/pubmed/23868369. Published online July 19, 2013. Accessed July 27, 2013.
Raja Rao MP, Panduranga P, Sulaiman K, and Al-Jufail. Digoxin Toxicity with Normal Digoxin and Serum Potassium Levels: Beware of Magnesium, the Hidden Malefactor. J Emerg Med. Abstract available online at https://www.ncbi.nlm.nih.gov/pubmed/23685098. Published May 16, 2013. Accessed July 27, 2013.
For Consumers: Avoiding Drug Interactions. U.S. Food and Drug Administration. Available online at https://www.fda.gov/ForConsumers/ConsumerUpdates/UCM096386. Last updated November 28, 2008. Accessed July 26, 2013.
Digoxin Oral Interactions. WebMD. Available online at https://www.webmd.com/drugs/drug-4358-Digoxin+Oral.aspx?drugid=4358&drugname=Digoxin+Oral. Last updated March 2013. Accessed July 31, 2013.
2016 review by Nicholas Heger, PhD, CC (NRCC), Assistant Director – Clinical Chemistry, Tufts Medical Center Boston.
Yancy CW, Jessup M, Bozkurt B, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240-e327.
Baselt, Randall C. (©2014). Disposition of Toxic Drugs and Chemicals in Man 10th edition: Biomedical Publications, Seal Beach, CA. Pp 656-659.
Bilbault P1, Oubaassine R, Rahmani H, Lavaux T, Castelain V, Sauder P, Schneider F. Emergency step-by-step specific immunotherapy in severe digoxin poisoning: an observational cohort study. Eur J Emerg Med. 2009 Jun;16(3):145-9.
Brent, Jeffrey; Wallace, Kevin; Burkhart, Keith; Phillips, Scott and Donovan, J. Ward. (© 2005). Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned Patient, 1st edition. Mosby, Inc., Philadelphia, PA. Pp. 1325-1333.